Literature DB >> 27488446

[Diagnostics and treatment of polymyalgia rheumatica].

C Dejaco1, E L Matteson2, F Buttgereit3.   

Abstract

Polymyalgia rheumatica (PMR) is the most common autoimmune inflammatory disease in older persons with an average age of onset of 73 years. Typical symptoms include acute or subacute bilateral shoulder pain with severe stiffness and often neck and bilateral hip pain. Giant cell arteritis (GCA) occurs in approximately 20 % of cases and up to two thirds of patients with GCA have symptoms of PMR. There are many disease which mimic PMR, elderly onset rheumatoid arthritis is frequently misdiagnosed as PMR. Although there are no specific laboratory tests, C‑reactive protein and erythrocyte sedimentation rates are elevated in over 90 % of patients. The diagnosis may be aided by imaging, especially ultrasonography and magnetic resonance imaging (MRI). Treatment currently consists of glucocorticoids at an initial dose of 12.5-25 mg prednisone equivalent daily. Treatment duration is typically 2‑3 years but may be longer. Under certain conditions low-dose methotrexate can be used as adjuvant therapy.

Entities:  

Keywords:  Arthritis; Autoimmune diseases; Epidemiology; Monitoring; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27488446     DOI: 10.1007/s00393-016-0105-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  56 in total

1.  EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Authors:  J N Hoes; J W G Jacobs; M Boers; D Boumpas; F Buttgereit; N Caeyers; E H Choy; M Cutolo; J A P Da Silva; G Esselens; L Guillevin; I Hafstrom; J R Kirwan; J Rovensky; A Russell; K G Saag; B Svensson; R Westhovens; H Zeidler; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-07-27       Impact factor: 19.103

2.  Long-term follow-up of polymyalgia rheumatica: evidence for synovitis.

Authors:  L A Healey
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

3.  Ultrasonography in early assessment of elderly patients with polymyalgic symptoms: a role in predicting diagnostic outcome?

Authors:  P Falsetti; C Acciai; A Volpe; L Lenzi
Journal:  Scand J Rheumatol       Date:  2010-07-24       Impact factor: 3.641

4.  Polymyalgia Rheumatica and its Association with Cancer.

Authors:  Emily C Pfeifer; Cynthia S Crowson; Brittny T Major; Eric L Matteson
Journal:  Rheumatology (Sunnyvale)       Date:  2015-05-07

5.  Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.

Authors:  M Lopez-Hoyos; C Ruiz de Alegria; R Blanco; J Crespo; M Peña; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Rheumatology (Oxford)       Date:  2004-02-17       Impact factor: 7.580

6.  Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Authors:  M C van der Goes; J W G Jacobs; M Boers; T Andrews; M A M Blom-Bakkers; F Buttgereit; N Caeyers; E H Choy; M Cutolo; J A P Da Silva; L Guillevin; M Holland; J R Kirwan; J Rovensky; K G Saag; G Severijns; S Webber; R Westhovens; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2009-09-17       Impact factor: 19.103

Review 7.  [Polymyalgia rheumatica].

Authors:  C Duftner; C Dejaco; M Schirmer
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

Review 8.  Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Anawin Sanguankeo; Sikarin Upala; Eric L Knight
Journal:  Semin Arthritis Rheum       Date:  2014-06-26       Impact factor: 5.532

9.  2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Authors:  Christian Dejaco; Yogesh P Singh; Pablo Perel; Andrew Hutchings; Dario Camellino; Sarah Mackie; Andy Abril; Artur Bachta; Peter Balint; Kevin Barraclough; Lina Bianconi; Frank Buttgereit; Steven Carsons; Daniel Ching; Maria Cid; Marco Cimmino; Andreas Diamantopoulos; William Docken; Christina Duftner; Billy Fashanu; Kate Gilbert; Pamela Hildreth; Jane Hollywood; David Jayne; Manuella Lima; Ajesh Maharaj; Christian Mallen; Victor Martinez-Taboada; Mehrdad Maz; Steven Merry; Jean Miller; Shunsuke Mori; Lorna Neill; Elisabeth Nordborg; Jennifer Nott; Hannah Padbury; Colin Pease; Carlo Salvarani; Michael Schirmer; Wolfgang Schmidt; Robert Spiera; David Tronnier; Alexandre Wagner; Madeline Whitlock; Eric L Matteson; Bhaskar Dasgupta
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

10.  2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Authors:  Bhaskar Dasgupta; Marco A Cimmino; Hilal Maradit-Kremers; Wolfgang A Schmidt; Michael Schirmer; Carlo Salvarani; Artur Bachta; Christian Dejaco; Christina Duftner; Hanne Slott Jensen; Pierre Duhaut; Gyula Poór; Novák Pál Kaposi; Peter Mandl; Peter V Balint; Zsuzsa Schmidt; Annamaria Iagnocco; Carlotta Nannini; Fabrizio Cantini; Pierluigi Macchioni; Nicolò Pipitone; Montserrat Del Amo; Georgina Espígol-Frigolé; Maria C Cid; Víctor M Martínez-Taboada; Elisabeth Nordborg; Haner Direskeneli; Sibel Zehra Aydin; Khalid Ahmed; Brian Hazleman; Barbara Silverman; Colin Pease; Richard J Wakefield; Raashid Luqmani; Andy Abril; Clement J Michet; Ralph Marcus; Neil J Gonter; Mehrdad Maz; Rickey E Carter; Cynthia S Crowson; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2012-04       Impact factor: 19.103

View more
  3 in total

Review 1.  [S3 guidelines on treatment of polymyalgia rheumatica : Evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of Rheumatology and Rehabilitation (ÖGR) and the Swiss Society of Rheumatology (SGT) and participating medical scientific specialist societies and other organizations].

Authors:  F Buttgereit; T Brabant; H Dinges; I Hiemer; M Kaplani; U Kiltz; D Kyburz; A Reißhauer; M Schneider; C Weseloh; C Dejaco
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

2.  Large vessel vasculitis with rare presentation of acute rhabdomyolysis: A case report and review of literature.

Authors:  Lan-Jun Fu; Shou-Ci Hu; Wen Zhang; Li-Qing Ye; Hong-Bo Chen; Xiao-Jun Xiang
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

3.  [Imaging diagnostics in large vessel vasculitis].

Authors:  W A Schmidt; W Hartung
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.